Ipca Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

1582.50

-12.45 (-0.78%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

1582.50

-12.45 (-0.78%)
16:02 Dec 20

Quality

77/100
High Financial Strength

Valuation

29/100
Expensive Valuation

Technical

70/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	5419.99	5829.79	6244.32	7705.04	8533.4
Operating Expenses +	3875.64	4520.53	5317.55	6383.88	7045.97
Raw Material	1923.09	2144.5	2205.84	2706.39	2806.71
Increase Decrease in Cost	-194.79	-129.65	100.67	-130.64	-21.82
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	1013.57	1177.39	1287.64	1708.43	1922.76
Miscellaneous Expenses	1785.67	2288.89	2717.78	3079.84	2338.32
Operating Profit	1544.35	1309.26	926.77	1321.16	1487.43
Other Income	62.84	66.57	125.62	124.77	88.24
Depreciation	209.17	232.42	261.56	357.24	396.87
Interest	9.04	7.69	45.54	138.27	109.38
Profit before tax and exceptio..	1388.98	1135.72	745.29	950.42	1069.42
Exceptional Items	0	0	0	-107.75	-68.71
PBT	1388.98	1135.72	745.29	842.67	1138.13
Provision for Taxation	240.14	224.77	253.36	313.46	330.73
Net Profit	1148.84	910.95	491.93	529.21	669.98
NET Profit after MI	1140.01	884.08	471.32	547.35	661.19
EPS	45.01	34.85	18.58	21.57	26.07
Operating Profit Margin (%)	28.49	22.46	14.84	17.15	17.43
Net Profit Margin (%)	21.03	15.16	7.55	7.1	7.75

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	46.30	46.30	46.30	46.30	46.30
FII	10.80	10.80	10.50	10.30	9.90
MF	28.60	28.50	28.80	29.20	30.20
Public	8.60	9.10	8.80	8.90	8.80
Others	0.10	0.00	0.00	0.00	0.00
Others	5.60	5.30	5.60	5.30	4.80